Europe made chemicals answer to one evidence system
Modern Europe is made from chemicals: medicines, semiconductors, paints, batteries, insulation, cleaners, textiles, wind turbines and water treatment all depend on them. The achievement is not a continent without chemical risk. It is that Europe built one public system requiring industry to name substances, produce evidence, explain uses and answer to shared rules across a continental market.
No data, no market
REACH—Registration, Evaluation, Authorisation and Restriction of Chemicals—entered into force in 2007 and created the European Chemicals Agency in Helsinki. Its decisive reversal was captured by 'no data, no market'. Manufacturers and importers generally cannot place a substance on the EU/EEA market at one tonne or more per year without a registration. The burden of assembling safety information moved toward the companies that make or import the chemical rather than leaving public authorities to discover every risk from scratch.
Registration creates a common evidence spine. Companies identify the substance, describe its properties and uses, provide classification and safe-use information and, at higher tonnages, submit more extensive hazard data and a chemical safety report. Registrants of the same substance normally share a joint submission so core evidence is not needlessly duplicated. The dossiers move through REACH-IT and use IUCLID, a structured format developed with international partners that also supports chemical assessment beyond Europe.
The world's largest public chemicals database
The scale is a European scientific asset. ECHA reports information on more than 23,000 of the chemicals most used in Europe and describes its wider repository as the world's largest chemicals database. ECHA CHEM is the newer publication platform for registration, classification and regulatory information. A worker, company, scientist, authority or citizen can search a substance and connect hazard descriptions, classification, uses, tonnage bands and regulatory activity that once sat across scattered national or company records.
Transparency needs an honest footnote. Registration information begins with company submissions, and ECHA states that it does not verify every disseminated item before publication. Confidentiality can protect defined commercial information, data quality varies and one substance can have complex identities or uses. The database is therefore an extraordinary map and starting point—not a guarantee that every field is correct, complete or a substitute for the legally controlling restriction, authorisation or classification text.
Evaluation turns submissions into accountable evidence
Evaluation is how the system tests that evidence. ECHA can run full or targeted compliance checks, examine testing proposals and issue binding decisions requiring missing information. Member states evaluate selected substances where a possible risk needs clarification. From 2009 through 2025, ECHA issued more than 4,800 evaluation decisions containing more than 16,300 information requests on over 3,000 substances. In 2025 alone, 214 compliance checks covered almost 1,200 registration dossiers and 196 substances.
Those numbers show both capability and unfinished work. Follow-up in 2025 covered 241 substances; around 70% reached compliance with the information decision, while the remaining cases were referred to national enforcement because required information had not arrived. Europe should be proud of a system that can expose missing evidence, not pretend missing evidence has vanished. Registration is the entry point; checking, updating and enforcement make it credible.
Classification, the Candidate List, authorisation and restriction
Risk management then offers several routes rather than one blunt ban. Classification and labelling communicate hazards across supply chains under the related CLP framework. A substance of very high concern can enter the Candidate List, creating information duties and making it eligible for authorisation controls. Placement on the Authorisation List can require companies to obtain permission for a use after a sunset date. Restrictions can limit or prohibit manufacture, sale or use where an unacceptable risk needs Union-wide control.
The Candidate List contained 253 entries when reviewed on 15 October 2026. Inclusion is not itself a universal prohibition: it is a formal signal with legal consequences, including communication duties for articles containing the substance above the relevant threshold. Authorisation and restriction are different legal processes with their own evidence, consultations and final decisions. Keeping those stages distinct matters when a headline claims that Europe has 'banned' a chemical.
Shared committees and national enforcement
ECHA's committees make shared expertise operational. The Member State Committee works toward agreement on identification and evaluation questions. The Committee for Risk Assessment examines scientific risk; the Committee for Socio-economic Analysis considers the benefits and costs of proposed restrictions or authorisations; the Biocidal Products Committee and other bodies cover additional mandates. Their opinions feed Commission and member-state decisions, with consultations allowing companies, researchers, unions, NGOs and citizens to submit evidence.
National institutions remain indispensable. Member-state authorities contribute experts, propose substances, evaluate dossiers and enforce duties through inspections and sanctions. ECHA's Forum coordinates enforcement projects so inspectors can test similar obligations across many countries, but ECHA is not a continental chemical police force. Customs, labour inspectorates, environmental authorities and market-surveillance bodies decide whether a legal rule becomes real in a factory, warehouse, import channel or online marketplace.
A common rulebook for industry
Europe also built an economic rulebook. One registration framework lets a compliant dossier support access across the EU/EEA instead of repeating twenty-seven systems. Shared substance identities and safety data improve supply-chain communication. Common restrictions can prevent a country with weaker rules from becoming the route into the whole market. Companies bear substantial testing, data-sharing, specialist and administration costs, especially difficult for smaller firms, but common rules also reward safer chemistry and reduce the uncertainty of incompatible national regimes.
Animal testing, new mandates and PFAS
Animal testing is one of the hardest tensions. REACH requires vertebrate-animal testing only as a last resort and obliges registrants to share data, use available information and consider alternatives such as read-across, computer models and non-animal methods. Some tests are still legally required where no adequate alternative can answer a serious hazard question. ECHA's 2026 report on alternatives tracks the evidence rather than claiming the ethical and scientific problem is solved.
The agency now carries responsibilities beyond the original REACH machinery, including classification and labelling, biocides, hazardous chemical exports, persistent organic pollutants, poison-centre notifications, drinking-water materials and growing environmental tasks. That expansion lets one knowledge centre connect related evidence. It also creates capacity and funding pressure. A Commission proposal for a dedicated ECHA basic regulation and work on a REACH revision were still legislative work in 2026, not completed law.
PFAS illustrates why calm institutional capacity matters. Thousands of highly persistent substances span very different uses, exposure paths and alternatives. A broad restriction proposal from five national authorities requires ECHA committees to assess large volumes of evidence, sector by sector, before an opinion and eventual Commission decision. Public urgency is justified, but a proposal, consultation, committee opinion and adopted restriction are not interchangeable milestones.
Imports remain the next enforcement test
Imports and articles remain a central test. European manufacturers can document a substance deeply while a finished item arrives through a long global supply chain with weaker information. REACH, CLP, product-safety rules, customs work and newer databases can connect parts of the problem, but online sales, enforcement capacity and traceability still leave gaps. Europe leads most convincingly when its market power is matched by inspection, usable data and cooperation with suppliers outside Europe—not when regulation exists only on paper.
Why chemicals safety is federal capacity
The system belongs beside Europe's other shared institutions. The European medicines network pools specialised evidence for medicines; ECDC connects health-threat surveillance; and the EU emissions market makes industrial pollution measurable and accountable. ECHA and REACH add the chemical identity, hazard, use and control layer that industries and public authorities across those systems rely on.
A federal lesson is already embedded in the architecture. Chemicals and supply chains cross borders, scientific expertise is scarce and a restriction in one market affects every neighbour. Europe therefore registers once, publishes common data, shares scientific committees and adopts continental controls, while national authorities keep inspection power and local knowledge. The arrangement is neither a central monopoly nor loose coordination: it is pooled capacity with distributed enforcement.
Europe can be proud that it turned chemical safety into visible common infrastructure. The databases are public, decisions can be traced, committees expose reasoning, industry carries evidence duties and national authorities work from one legal frame. The next achievement must be faster risk management, better-quality dossiers, credible import enforcement, usable information for workers and consumers, and durable support for non-animal science. Those are tests of a system Europe has built—not reasons to deny that the system itself is a remarkable European accomplishment.
The Proud Europe series celebrates institutions that make interdependence governable. REACH does something quietly radical: it treats knowledge about a chemical sold across Europe as a shared public concern. ECHA gives that principle a home, a database, scientific procedures and a memory longer than any one government.